Caption Management’s Inovio Pharmaceuticals INO Stock Holding History

Caption Management’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,500	Closed	-$747K	–	1687
2021 Q4	$747K	Buy	+12,500	New	+$1M	0.01%	1148
2021 Q3	–	Sell	-8,333	Closed	-$928K	–	1635
2021 Q2	$928K	Buy	+8,333	New	+$800K	0.01%	921
2020 Q4	–	Sell	-54,125	Closed	-$7.54M	–	1105
2020 Q3	$7.54M	Buy	54,125 +12,208	+29%	+$2.55M	0.18%	134
2020 Q2	$13.6M	Buy	+41,917	New	+$6.73M	0.45%	27

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Caption Management's INO Position: Q2 2026 in Review

Caption Management opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 478,950 shares worth $527K. The stake represents ﹤0.01% of the portfolio and ranks #1310 among its holdings. This is a return to the name: Caption Management previously reported a position in INO as recently as Q4 2021.

Caption Management first reported a position in INO in Q4 2021 and has held it in 2 quarters since. The position peaked at $590K in Q4 2021. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Caption Management held 478,950 shares of Inovio Pharmaceuticals worth $527K as of Q2 2026.
Inovio Pharmaceuticals was a new Caption Management position in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1310 holding.
Caption Management first reported a position in Inovio Pharmaceuticals in Q4 2021 and has held it in 2 quarters since.
Caption Management's Inovio Pharmaceuticals position peaked at $590K in Q4 2021.
102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.